BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 1, 2026
See today's BioWorld
Home
» Seeking Alternatives, Optimer Attains Eligible Bachelor Status
To read the full story,
subscribe
or
sign in
.
Seeking Alternatives, Optimer Attains Eligible Bachelor Status
Feb. 28, 2013
By
Catherine Shaffer
A minor note in Optimer Pharmaceuticals Inc.'s board appointment announcement set the markets speculating on a potential merger for the San Diego-based company.
BioWorld